ZUDDAS, ALESSANDRO
ZUDDAS, ALESSANDRO
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl pyridinium uptake in dissociated cell cultures from embryonic mesencephalon
1988-01-01 Schinelli, S; Zuddas, Alessandro; Kopin, Ij; Barker, Jl; DI PORZIO, U.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyrydyne (MPTP) neurotoxicity in mice is enhanced by ethanol or acethaldehyde
1987-01-01 Corsini, Gu; Zuddas, Alessandro; Bonucceli, B; Schinelli, S; Kopinij,
6R-Tetrahydrobiopterin induces dopamine synthesis in a human neuroblastoma cell line, LA-N-1: a cellular model of Dopa-responsive dystonia
2002-01-01 Zuddas, Alessandro; C., Mancosu; V., Lilliu; Sorrentino, G; DI PORZIO, U; C., Cianchetti
A comparison of North American versus non-North American ADHD study populations
2006-01-01 Jk, Buitelaar; J., Barton; M., Danckaerts; E., Friedrichs; Gillberg, C; Hazell, Pl; Hellemans, H; Johnson, M; Kalverdijk, Lj; Masi, G; Michelson, D; Revol, O; Sebastian, Js; Zhang, S; Zuddas, Alessandro
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD
2004-01-01 Buitelaar, J. K.; J., Gadoros; V., Harpin; P., Hazell; M., Johnson; T., LERMAN SAGIE; Soutullo, C. A.; T., Wolanczyk; P., Zeiner; Zuddas, Alessandro; Fouche, D. S.; J., KRIKKE WORKEL; S., Zhang; D., Michelson
A randomized, double-blind study of continuation treatment for ADHD after one year
2007-01-01 Buitelaar, J. K.; D., Michelson; M., Danckaerts; C., Gillberg; Spencer, T. J.; Zuddas, Alessandro; Faries, D. E.; S., Zhang; J., Biederman
Acetaldehyde directly enhances MPP+ toxicity and delays its elimination from the striatum
1989-01-01 Zuddas, Alessandro; Corsini, Gu; Schinelli, S; Barker, Jl; Kopin, Ij; DI PORZIO, U.
ADHD and hyperkinetic disorder
2015-01-01 Tobias, Banaschewski; Zuddas, Alessandro; Philip, Asherson; Jan, Buitelaar; David, Coghill; Marina, Danckaerts; Manfred, Döpfner; Luis Augusto, Rohde; Edmund Sonuga, Barke; Eric, Taylor
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
2020-01-01 Cortese, S.; Asherson, P.; Sonuga-Barke, E.; Banaschewski, T.; Brandeis, D.; Buitelaar, J.; Coghill, D.; Daley, D.; Danckaerts, M.; Dittmann, R. W.; Doepfner, M.; Ferrin, M.; Hollis, C.; Holtmann, M.; Konofal, E.; Lecendreux, M.; Santosh, P.; Rothenberger, A.; Soutullo, C.; Steinhausen, H. -C.; Taylor, E.; Van der Oord, S.; Wong, I.; Zuddas, A.; Simonoff, E.
Antipsychotics for non-psychotic disorders
2009-01-01 Zuddas, Alessandro; Paba, S; Usala, T.
Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns
2009-01-01 Vitiello, B; Correll, C; VAN ZWIETEN BOOT, B; Zuddas, Alessandro; Parellada, M; Arango, C.
Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion
1991-01-01 Bankiewicz, Ks; Oldfield, Eh; Plunkett, Rj; Schuette, Wh; Cogank, Dg; Hogan, N; Zuddas, Alessandro; Kopin, Ij
Are risperidone safety and tolerability in children and adolescents modulated by diagnosis? A retrospective chart review
2009-01-01 Paba, Silvia; Lecca, L; Testa, M; Atzori, P; Zuddas, Alessandro
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog”
2021-01-01 Gagliano, A.; Puligheddu, M.; Ronzano, N.; Congiu, P.; Tanca, M. G.; Cursio, I.; Carucci, S.; Sotgiu, S.; Grossi, E.; Zuddas, A.
Association of Risk of Suicide Attempts With Methylphenidate Treatment
2017-01-01 Man, Kenneth K. C; Coghill, David; Chan, Esther W; Lau, Wallis C. Y; Hollis, Chris; Liddle, Elizabeth; Banaschewski, Tobias; Mccarthy, Suzanne; Neubert, Antje; Sayal, Kapil; Ip, Patrick; Schuemie, Martijn J; Sturkenboom, Miriam C. J. M; Sonuga Barke, Edmund; Buitelaar, Jan; Carucci, Sara; Zuddas, Alessandro; Kovshoff, Hanna; Garas, Peter; Nagy, Peter; Inglis, Sarah K; Konrad, Kerstin; Häge, Alexander; Rosenthal, Eric; Wong, Ian C. K.
The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families.
2012-01-01 Prandini, P; Pasquali, A; Malerba, G; Marostica, A; Zusi, C; Xumerle, L; Muglia, P; DA ROS, L; Ratti, E; Trabetti, E; Pignatti, Pf; ITALIAN AUTISM NETWORK, Incl; Zuddas, Alessandro
Atomoxetine Hydrochloride in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder: results from a placebo-controlled Italian study
2009-01-01 G., Dellagnello; D., Maschietto; A., Pascotto; F., Calamoneri; G., Masi; P., Curatolo; D., Besana; F., Mancini; A., Rossi; L., Poole; R., Escobar; Zuddas, Alessandro
Atomoxetine in the long-term prevention of relapse in ADHD
2004-01-01 Michelson, D; Buitelaar, Jk; Danckaerts, M; Gillberg, C; Spencer, Tj; Zuddas, Alessandro; Zhang, S; Biederman, J.
Atomoxetine in the long-term prevention of relapse in ADHD
2003-01-01 Michelson, D; Buitelaar, J; Danckaerts, D; Gillberg, C; Spencer, Tj; Zuddas, Alessandro; Zhang, S; Biederman, . J.
Attention Deficit Hyperactivity Disorder
2009-01-01 T., Banaschewski; D., Coghill; M., Dankaers; M., Döpfne; L., Rohde; Sergeant, J. S.; SONUGA BARKE, E. J. S.; E., Taylor; Zuddas, Alessandro
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl pyridinium uptake in dissociated cell cultures from embryonic mesencephalon | 1-gen-1988 | Schinelli, S; Zuddas, Alessandro; Kopin, Ij; Barker, Jl; DI PORZIO, U. | JOURNAL OF NEUROCHEMISTRY | - |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrydyne (MPTP) neurotoxicity in mice is enhanced by ethanol or acethaldehyde | 1-gen-1987 | Corsini, Gu; Zuddas, Alessandro; Bonucceli, B; Schinelli, S; Kopinij, | LIFE SCIENCES | - |
| 6R-Tetrahydrobiopterin induces dopamine synthesis in a human neuroblastoma cell line, LA-N-1: a cellular model of Dopa-responsive dystonia | 1-gen-2002 | Zuddas, Alessandro; C., Mancosu; V., Lilliu; Sorrentino, G; DI PORZIO, U; C., Cianchetti | BRAIN RESEARCH | - |
| A comparison of North American versus non-North American ADHD study populations | 1-gen-2006 | Jk, Buitelaar; J., Barton; M., Danckaerts; E., Friedrichs; Gillberg, C; Hazell, Pl; Hellemans, H; Johnson, M; Kalverdijk, Lj; Masi, G; Michelson, D; Revol, O; Sebastian, Js; Zhang, S; Zuddas, Alessandro | EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | - |
| A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD | 1-gen-2004 | Buitelaar, J. K.; J., Gadoros; V., Harpin; P., Hazell; M., Johnson; T., LERMAN SAGIE; Soutullo, C. A.; T., Wolanczyk; P., Zeiner; Zuddas, Alessandro; Fouche, D. S.; J., KRIKKE WORKEL; S., Zhang; D., Michelson | EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | - |
| A randomized, double-blind study of continuation treatment for ADHD after one year | 1-gen-2007 | Buitelaar, J. K.; D., Michelson; M., Danckaerts; C., Gillberg; Spencer, T. J.; Zuddas, Alessandro; Faries, D. E.; S., Zhang; J., Biederman | BIOLOGICAL PSYCHIATRY | - |
| Acetaldehyde directly enhances MPP+ toxicity and delays its elimination from the striatum | 1-gen-1989 | Zuddas, Alessandro; Corsini, Gu; Schinelli, S; Barker, Jl; Kopin, Ij; DI PORZIO, U. | BRAIN RESEARCH | - |
| ADHD and hyperkinetic disorder | 1-gen-2015 | Tobias, Banaschewski; Zuddas, Alessandro; Philip, Asherson; Jan, Buitelaar; David, Coghill; Marina, Danckaerts; Manfred, Döpfner; Luis Augusto, Rohde; Edmund Sonuga, Barke; Eric, Taylor | - | Oxford University Press |
| ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group | 1-gen-2020 | Cortese, S.; Asherson, P.; Sonuga-Barke, E.; Banaschewski, T.; Brandeis, D.; Buitelaar, J.; Coghill, D.; Daley, D.; Danckaerts, M.; Dittmann, R. W.; Doepfner, M.; Ferrin, M.; Hollis, C.; Holtmann, M.; Konofal, E.; Lecendreux, M.; Santosh, P.; Rothenberger, A.; Soutullo, C.; Steinhausen, H. -C.; Taylor, E.; Van der Oord, S.; Wong, I.; Zuddas, A.; Simonoff, E. | THE LANCET CHILD & ADOLESCENT HEALTH | - |
| Antipsychotics for non-psychotic disorders | 1-gen-2009 | Zuddas, Alessandro; Paba, S; Usala, T. | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - |
| Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns | 1-gen-2009 | Vitiello, B; Correll, C; VAN ZWIETEN BOOT, B; Zuddas, Alessandro; Parellada, M; Arango, C. | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - |
| Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion | 1-gen-1991 | Bankiewicz, Ks; Oldfield, Eh; Plunkett, Rj; Schuette, Wh; Cogank, Dg; Hogan, N; Zuddas, Alessandro; Kopin, Ij | BRAIN RESEARCH | - |
| Are risperidone safety and tolerability in children and adolescents modulated by diagnosis? A retrospective chart review | 1-gen-2009 | Paba, Silvia; Lecca, L; Testa, M; Atzori, P; Zuddas, Alessandro | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - |
| Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” | 1-gen-2021 | Gagliano, A.; Puligheddu, M.; Ronzano, N.; Congiu, P.; Tanca, M. G.; Cursio, I.; Carucci, S.; Sotgiu, S.; Grossi, E.; Zuddas, A. | NATURE AND SCIENCE OF SLEEP | - |
| Association of Risk of Suicide Attempts With Methylphenidate Treatment | 1-gen-2017 | Man, Kenneth K. C; Coghill, David; Chan, Esther W; Lau, Wallis C. Y; Hollis, Chris; Liddle, Elizabeth; Banaschewski, Tobias; Mccarthy, Suzanne; Neubert, Antje; Sayal, Kapil; Ip, Patrick; Schuemie, Martijn J; Sturkenboom, Miriam C. J. M; Sonuga Barke, Edmund; Buitelaar, Jan; Carucci, Sara; Zuddas, Alessandro; Kovshoff, Hanna; Garas, Peter; Nagy, Peter; Inglis, Sarah K; Konrad, Kerstin; Häge, Alexander; Rosenthal, Eric; Wong, Ian C. K. | JAMA PSYCHIATRY | - |
| The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families. | 1-gen-2012 | Prandini, P; Pasquali, A; Malerba, G; Marostica, A; Zusi, C; Xumerle, L; Muglia, P; DA ROS, L; Ratti, E; Trabetti, E; Pignatti, Pf; ITALIAN AUTISM NETWORK, Incl; Zuddas, Alessandro | PSYCHIATRIC GENETICS | - |
| Atomoxetine Hydrochloride in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder: results from a placebo-controlled Italian study | 1-gen-2009 | G., Dellagnello; D., Maschietto; A., Pascotto; F., Calamoneri; G., Masi; P., Curatolo; D., Besana; F., Mancini; A., Rossi; L., Poole; R., Escobar; Zuddas, Alessandro | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - |
| Atomoxetine in the long-term prevention of relapse in ADHD | 1-gen-2004 | Michelson, D; Buitelaar, Jk; Danckaerts, M; Gillberg, C; Spencer, Tj; Zuddas, Alessandro; Zhang, S; Biederman, J. | EUROPEAN PSYCHIATRY | - |
| Atomoxetine in the long-term prevention of relapse in ADHD | 1-gen-2003 | Michelson, D; Buitelaar, J; Danckaerts, D; Gillberg, C; Spencer, Tj; Zuddas, Alessandro; Zhang, S; Biederman, . J. | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - |
| Attention Deficit Hyperactivity Disorder | 1-gen-2009 | T., Banaschewski; D., Coghill; M., Dankaers; M., Döpfne; L., Rohde; Sergeant, J. S.; SONUGA BARKE, E. J. S.; E., Taylor; Zuddas, Alessandro | - | Oxford University Press |